AUW Antimicrobial Research Center
The threat is multi-drug resistance. The solution is interdisciplinary. Discovering novel compounds through AI, phages, and marine ecosystems.
Our Focus
Computational
AI-driven de novo compound development.
Experimental
High-specificity phage therapy solutions.
Analytical
Marine bio-resource extraction & isolation.
Collaborative
Global partnerships in the fight against AMR.
Active Research Projects
We are currently translating our three core strategies into actionable science. Explore our ongoing, funded projects tackling the most critical challenges in multi-drug-resistant pathogens.
De Novo Peptide Generation
Phage Cocktails for MDR P. aeruginosa
Benthic Marine Bio-prospecting
Recent Publications
By training deep neural networks, we discovered an entirely new class of structural antibiotics targeting multi-drug resistant pathogens, as published in Nature Medicine (2025).
We engineered a highly specific synthetic peptide sequence that effectively penetrates and dismantles bacterial biofilms of Pseudomonas aeruginosa, featured in the Journal of Medicinal Chemistry.
Our comparative genomic analysis revealed key evolutionary pathways and mutation timelines of carbapenem resistance in Klebsiella pneumoniae, detailed in The Lancet Infectious Diseases.
Using high-throughput spatial transcriptomics, we mapped the active metabolic microenvironment of resistant osteomyelitis infections, published in Science Translational Medicine.
We established an open-access, real-time global sequencing database to predict and track the emergence of novel resistant strains, reported in Nucleic Acids Research.
